Immunogenicity and Safety Study to Evaluate Different Formulations of GSK Biologicals' Influenza Vaccine GSK576389A

NCT00540592 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

2007

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: GlaxoSmithKline Biologicals' influenza vaccine GSK576389A
BIOLOGICAL: Fluarix

Sponsor

GlaxoSmithKline